Jump to content

Hypopituitary Control and Complications Study

Recommended Posts

  • Chief Cushie



Summary: Hypopituitary Control and Complications Study

Dr. Stanley Korenman of UCLA's Division of Endocrinology is conducting a study to look at the effects of the long-term use of Growth Hormone Therapy (Humatrope, an FDA approved medication). The study involves measurements of blood levels of hormones, bone density and body fat every 6 months for 5 years (a total of 11 visits).


Study Criteria:


Be over 18 years of age

Have known pituitary disease, either as a child or as a result of pituitary tumors

Be taking hormone replacement

Have health insurance

Be interested in Growth Hormone Therapy




Care Felix, Clinical Research Coordinator

UCLA Medical Center

Office of Clinical Trials

10900 Wilshire Blvd, Suite 170

Los Angeles, CA 90024

Telephone: 310-794-8900

Fax: 310-794-8902

Email: cfelix@mednet.ucla.edu

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...